Menu Search
Equities

Carmell Corp

CTCX:NAQ

Carmell Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4114
  • Today's Change0.021 / 5.49%
  • Shares traded87.38k
  • 1 Year change-91.11%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Carmell Corp increased its cash reserves by 2,172.70%, or 2.78m. Cash Flow from Financing totalled 11.16m or -- of revenues. In addition the company used 8.35m for operations while cash used for investing totalled 30.47k.
Cash flow per share-0.7965
Price/Cash flow per share--
Book value per share-0.0656
Tangible book value per share-0.0667
More ▼

Balance sheet in USDView more

Carmell Corp uses little or no debt in its capital structure.
Current ratio0.7098
Quick ratio0.6901
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.